As of Jun 15
| +1.36 / +1.13%|
The 20 analysts offering 12-month price forecasts for Alexion Pharmaceuticals Inc have a median target of 163.50, with a high estimate of 184.00 and a low estimate of 115.00. The median estimate represents a +34.55% increase from the last price of 121.52.
The current consensus among 21 polled investment analysts is to Buy stock in Alexion Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.